LG Chem initiates phase 2 clinical trials in patients with defects in MC4R pathway causing obesity and hyperphagia
LG Chem is making progress in the development of the world's first oral treatment for rare forms of obesity.
LG Chem is making progress in the development of the world's first oral treatment for rare forms of obesity.
Three block copolymers added to RESOMER portfolio of bioabsorbable polymers
The VitalDose Drug Delivery Platform has been used in patient-centric dose forms in women’s health for over two decades
In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs
Parecoxib Sodium is the first parenteral selective COX-2 inhibitor available for clinical use in pain management
Brian Foard will lead the Specialty Care GBU ad interim, effective immediately.
In Phase I studies, ZYIL1 was found to be safe and well-tolerated in human volunteers
Proteolysis Targeting Chimeras (PROTACs) technology as potential new method for mosquito-borne disease control
DKSH has further fortified its strategic partnership with Biolin Scientific, a globally recognized pioneer in surface science instrumentation, across nine key markets in the APAC region
Subscribe To Our Newsletter & Stay Updated